4 completed, 1 unknown. 5 Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 5 | Completed 4, Unknown 1 |
Follow Contraceptive Usage: new trials by email Literature Review of Contraceptive Usage trials Research Report on Contraceptive Usage
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Testing a Modified Family Planning Intervention for Postpartum Women in Uganda Contraceptive management program - Contraceptive Usage | Phase 1 | Unknown | University of Vermont | 20 | 2019-08-05 | 2019-08-28 |
| PK Study of 90-Day Use of Vaginal Rings Containing Dapivirine and Levonorgestrel VR: 200 mg DPV + 320 mg LNG - Healthy, Contraception | Phase 1 | Completed | International Partnership for Microbicides, Inc. | 25 | 2018-07-17 | 2019-10-09 |
| Safety, PK, and PD Study of IVRs Releasing TFV and LNG TFV/LNG IVR, Placebo - Anti-Infective Agents, Anti-Retroviral Agents | Phase 1 | Completed | CONRAD | 66 | 2017-09-28 | 2019-07-23 |
| Improving Effective Contraceptive Use Among Opioid-maintained Women Contraceptive management program, Usual care - Contraceptive Usage, Opioid Dependence | Phase 1 | Completed | University of Vermont | 31 | 2011-10-01 | 2015-03-17 |
| A Phase I Study to Evaluate the PK and PD of a Single Injection of Levonorgestrel Butanoate for Female Contraception levonorgestrel butanoate - Contraceptive Usage | Phase 1 | Completed | Premier Research | 16 | 2011-05-01 | 2016-02-22 |
Contraception Behavior (5) · Opioid-Related Disorders (1) · Sexually Transmitted Diseases (1)
Behavior (5) · Reproductive Behavior (5) · Chemically-Induced Disorders (1) · Communicable Diseases (1) · Disease Attributes (1) · Genital Diseases (1) · Infections (1) · Mental Disorders (1) · Narcotic-Related Disorders (1) · Pathologic Processes (1) · Pathological Conditions, Signs and Symptoms (1) · Substance-Related Disorders (1) · Urogenital Diseases (1)
Tenofovir (1) · levonorgestrel butanoate (1)
University of Vermont (2) · CONRAD (1) · International Partnership for Microbicides, Inc. (1) · Premier Research (1)
United States (4) · Dominican Republic (1) · Uganda (1)
Sarah H. Heil, Ph.D. (1) · Sarah Heil, PhD (1)
PMID 35350436, PMID 35363574, PMID 36215267, PMID 39808648
5UM1AI068633 (1)